alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Inez Hereford BROWN, Appellant, v. UNITED STATES of America.

No. 11326.

Circuit Court of Appeals, Eighth Circuit.

Aug. 1, 1939.

Forest P. Tralles and Fred J. Hoffmeister, both of St. Louis, Mo., for appellant.

Harry C. Blanton, U. S. Atty., of Sikeston, Mo., Herbert H. Freer, Asst. U. S. Ally., of St. Louis, Mo., James W. Morris, Asst. Atty. Gen., and Andrew D. Sharpe and Leon F. Cooper, Sp. Assts. to Atty. Gen.

PER CURIAM.

Appeal, 21 F.Supp. 214, dismissed at cost of appellant, per stipulation of party.
**EXHIBIT 31.2**

I, J. WilliamHolden, III, certify that:

1.                I have reviewedthis Form 10-Q for the period ended June 30, 2007, of MirantAmericas Generation, LLC;

2.                Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.                Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.                The registrant’sother certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

a.                  Designed suchdisclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

b.                 Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c.                  Disclosed inthis report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter thathas materially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting.

5.                The registrant’sother certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the registrant’s board of managers (or persons performing theequivalent functions):

a.                  All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

b.                 Anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financialreporting.
| Date: August 13, 2007 |
|----------------------------|
| By:                        | /s/ J. WILLIAM HOLDEN, III |   |
| * *                   | J. William Holden III |
| * *                   | *Senior Vice President, Chief Financial Officer  and   Treasurer (Principal Financial Officer)* |

 

----
**EXHIBIT
      23.1**











**CONSENT
      OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**





We
      consent to the incorporation by reference in the Registration Statement (Form
      S-8 No. 33-81214) pertaining to the Employee Stock Ownership Plan and Trust
      of
      Tandy Leather Factory, Inc. and the Registration Statement (Form S-8 No.
      333-07147) pertaining to the 1995 Stock Option Plan of Tandy Leather Factory,
      Inc. of our report dated February 24, 2006, with respect to the consolidated
      financial statements and schedule of Tandy Leather Factory, Inc. included in
      the
      Annual Report (Form 10-K) for the year ended December 31, 2005.




















WEAVER
      AND TIDWELL, L.L.P.





Fort
      Worth, Texas


March
      27 ,
      2006
<PAGE>

                                                                     Exhibit 4.3
                        CONSUMER PORTFOLIO SERVICES, INC.
                            16355 Laguna Canyon Road
                            Irvine, California 92618

                              PURCHASE CONFIRMATION


[Investor name and address]                    STATEMENT DATE: __________,200___


TRANSACTION INFORMATION
-----------------------

SECURITY DESCRIPTION: Consumer Portfolio Services, Inc. Renewable Unsecured
Subordinated Note
TRANSACTION:  PURCHASE
TYPE OF OWNERSHIP: ____________
SSN: ____________________


NOTE ID  TERM     PURCHASE DATE     MATURITY DATE    PAYMENT SCHEDULE
-------  ----     -------------     -------------    -----------------



PRINCIPAL AMOUNT     INTEREST RATE    COMMISSION/FEES      NET AMOUNT
----------------     -------------    ---------------      ----------


NOTE: These securities are issued in book-entry form only; no physical
certificates will be provided.

INTEREST PAYMENT INFORMATION
----------------------------
ACCOUNT NAME:                                        BANK:
ACCOUNT #:                                           ROUTING NUMBER:
INTEREST PAYMENT METHOD: ACH (Direct Deposit)        FOR FURTHER CREDET:

Your interest payments will be automatically deposited directly into the account
listed above. Please verify the account information. If it is incorrect, please
call Sumner Harrington Investor Services at 800-234-5777.

All interest payments will be made in accordance with the Interest payment
schedule shown in the previous section. If your note pays interest monthly and
the monthly interest payment date you selected is within five business days of
the Purchase Date, your first interest payment will be made the following month
and will include all of the interest earned since the Note Issue Date. If an
interest payment date falls on a Saturday, Sunday, or legal holiday, the payment
will be made on the next business day.

SECURITIES OFFERED THROUGH SUMNER HARRINGTON LTD.
-------------------------------------------------
Sumner Harrington Ltd. was the selling agent for the Issuer in this transaction
and is sending you this confirmation statement on the Issuer's behalf. The
Issuer will pay Sumner Harrington Ltd. a commission of up to 3% of the Net
Amount plus other fees for its role in this transaction.

PLEASE CALL SUMNER HARRINGTON LTD. INVESTOR SERVICES AT 800-234-5777 IF YOU HAVE
ANY QUESTIONS.

Sumner Harrington Ltd.                                            (800) 234-5777
11100 Wayzata Blvd., Suite 170             investorservices@sumnerharrington.com
Minneapolis, MN  55305                                  www.sumnerharrington.com
# C_2011226EN.01002502.xml

| 30.7.2011 | EN | Official Journal of the European Union | C 226/25 |
| --- | --- | --- | --- |

30.7.2011

EN

Official Journal of the European Union

C 226/25

---

Judgment of the General Court of 16 June 2011 — Putters International v Commission

(Case T-211/08) (1)

1

(Competition - Cartels - International removal services market in Belgium - Decision finding an infringement of Article 81 EC - Price-fixing - Market-sharing - Bid rigging - Single and continuous infringement - Fines - 2006 Guidelines on the method of setting fines - Gravity - Duration)

2011/C 226/51

Language of the case: Dutch

Parties

Parties

Applicant: Putters International NV (Cargovil, Belgium) (represented by: K. Platteau, lawyer)

Applicant:

Defendant: European Commission (represented by: A. Bouquet and F. Ronkes Agerbeek, Agents)

Defendant:

Re:

Re:

Application for the partial annulment of Commission decision C(2008) 926 final of 11 March 2008 relating to a proceeding under Article 81 [EC] and Article 53 of the EEA Agreement (Case COMP/38.543 — International Removal Services), and, in the alternative, the annulment or reduction of the fine imposed on the applicant.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Putters International NV to pay the costs. |
| --- | --- |

2.

Orders Putters International NV to pay the costs.

---

(1)  OJ C 197, 2.8.2008.

1

---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ULTRATECH
STEPPER INC., FORM 10-K AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-1999
<PERIOD-START>                             OCT-01-1999             JAN-01-1999
<PERIOD-END>                               DEC-31-1999             DEC-31-1999
<CASH>                                          46,978                  46,978
<SECURITIES>                                    96,566                  96,566
<RECEIVABLES>                                   22,039                  22,039
<ALLOWANCES>                                     2,046                   2,046
<INVENTORY>                                     28,975                  28,975
<CURRENT-ASSETS>                               195,906                 195,906
<PP&E>                                          51,154                  51,154
<DEPRECIATION>                                  30,668                  30,668
<TOTAL-ASSETS>                                 236,808                 236,808
<CURRENT-LIABILITIES>                           32,305                  32,305
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                            21                      21
<OTHER-SE>                                     204,193                 204,193
<TOTAL-LIABILITY-AND-EQUITY>                   236,808                 236,808
<SALES>                                         23,397                  95,473
<TOTAL-REVENUES>                                27,647                 113,123
<CGS>                                           13,320                  56,471
<TOTAL-COSTS>                                   16,331                  68,703
<OTHER-EXPENSES>                                 7,382                  27,678
<LOSS-PROVISION>                                   344                     512
<INTEREST-EXPENSE>                                  74                     374
<INCOME-PRETAX>                                  (999)                 (4,168)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                              (999)                 (4,168)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                     (999)                 (4,168)
<EPS-BASIC>                                     (0.05)                  (0.20)
<EPS-DILUTED>                                   (0.05)                  (0.20)


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          22,994
<SECURITIES>                                         0
<RECEIVABLES>                                   30,502
<ALLOWANCES>                                       550
<INVENTORY>                                     31,542
<CURRENT-ASSETS>                               109,377
<PP&E>                                          59,168
<DEPRECIATION>                                  21,286
<TOTAL-ASSETS>                                 156,900
<CURRENT-LIABILITIES>                           49,343
<BONDS>                                         94,863
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            10
<OTHER-SE>                                      10,482
<TOTAL-LIABILITY-AND-EQUITY>                   156,900
<SALES>                                        260,944
<TOTAL-REVENUES>                               260,944
<CGS>                                          215,476
<TOTAL-COSTS>                                  248,887
<OTHER-EXPENSES>                                 (978)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              13,046
<INCOME-PRETAX>                                   (11)
<INCOME-TAX>                                     (366)
<INCOME-CONTINUING>                                355
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       355
<EPS-PRIMARY>                                     0.41
<EPS-DILUTED>                                     0.41
        

</TABLE>
**Exhibit 31.1**

 

**CERTIFICATIONS**

 

I, James W. Dennis, Chairman and Chief Executive Officer of HealtheTech, Inc., certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of HealtheTech, Inc.;

 

2. Based on my knowledge, this report does not contain anyuntrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and otherfinancial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4. The registrant’s other certifying officer(s) and I are responsiblefor establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designated under oursupervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Evaluated the effectiveness of theregistrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

c) Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financial reporting; and 

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financialreporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): 

 

a) All significant deficiencies and material weakness in the design or operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’sinternal control over financial reporting. 

 

Date: November 12, 2004
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Aging Special Emphasis Panel; Behavioral and Social Research Networks.                    

*Date:*                         February 29, 2024.                    

*Time:*                         11:00 a.m. to 4:00 p.m.                              ( print page 475)    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Carmen Moten, Ph.D., M.P.H., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, 7201 Wisconsin Avenue, Gateway Bldg., Suite 2C212, Bethesda, MD 20892, 301-402-7703,                         *cmoten@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)

Dated: December 28, 2023.

Miguelina Perez, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-28957 Filed 1-3-24; 8:45 am]

BILLING CODE 4140-01-P
#### Percival SPENCER, Plaintiff-Appellant, v. ALCOA STEAMSHIP COMPANY, Inc., Defendant-Appellee.

No. 152, Docket 28220.

United States Court of Appeals Second Circuit.

Argued Dec. 3, 1963.

Decided Dec. 9, 1963.

Fink, Frank & Gerringer, New York City (Jacquin Frank and Herman B. Gerringer, New York City, on the brief), for plaintiff-appellant.

Haight, Gardner, Poor & Havens, New York City (J. Ward O’Neill and Francis X. Byrn, New York City, of counsel), for defendant-appellee.

Before MOORE, FRIENDLY and KAUFMAN, Circuit Judges.

*958PER CURIAM.

We affirm the order declining jurisdiction and dismissing the action on the opinion of Judge Abruzzo, 221 F.Supp. 343 (E.D.N.Y.1963).
Exhibit 21

List of Subsidiaries



|                                 |  |                               |  |                                          
|-------------------------------- |  | ----------------------------- |  | -----------------------------------------
|Subsidiary*                      |  | Jurisdiction of Incorporation |  | Name Under which Subsidiary does Business
|                                 |  |                              
|Ingenex, Inc.                    |  | Delaware                      |  | This subsidiary is currently inactive    
|                                 |  |                              
|Developmental Therapeutics, Inc. |  | Delaware                      |  | Developmental Therapeutics               

---

|* | We own 100% of the outstanding common stock of Developmental Therapeutics, Inc. and 81% of the outstanding common stock of Ingenex, Inc.
|- | ----------------------------------------------------------------------------------------------------------------------------------------
Exhibit 32.3

Certification of Chief Accounting Officer

Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the quarter ended September 30, 2007(the Report) of MCG Capital Corporation (the Registrant), as filed with the
Securities and Exchange Commission on the date hereof, I, John C. Wellons, the Chief Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------



/s/    JOHN C. WELLONSName: John C. WellonsDate: November 1, 2007
I 

115TH CONGRESS 

2D SESSION H. R. 4759 

To amend the Federal Reserve Act to revise the membership of Federal 

Open Market Committee, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 10, 2018 

Mr. WILLIAMS introduced the following bill; which was referred to the 

Committee on Financial Services 

A BILL 

To amend the Federal Reserve Act to revise the membership 

of Federal Open Market Committee, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘FOMC Representation 

5 Improvement Act’’. 

6 SEC. 2. MEMBERSHIP OF FEDERAL OPEN MARKET COM7 MITTEE. 

8 Section 12A(a) of the Federal Reserve Act (12 

9 U.S.C. 263(a)) is amended— 


SSpencer on DSKBBXCHB2PROD with BILLS
2 

•HR 4759 IH

1 (1) in the first sentence, by striking ‘‘five rep2 resentatives of the Federal Reserve banks to be se3 lected as hereinafter provided’’ and inserting ‘‘one 

4 representative from each of the Federal Reserve 

5 banks’’; 

6 (2) in the second sentence, by striking ‘‘and, 

7 beginning’’ and all that follows through ‘‘San Fran8 cisco’’; and 

9 (3) by striking the third and fourth sentences. 

Æ 


SSpencer on DSKBBXCHB2PROD with BILLS